Welcome to the University of Colorado, Division of Maternal-Fetal Medicine. We provide clinical, educational and research services as part of the University of Colorado Department of OB-GYN. In partnership with the Colorado Fetal Care and UCHealth, we offer the entire spectrum of maternal and fetal care services with an advanced academic focus. We provide women with the full range of obstetric and maternal medicine expertise necessary to treat any complication a high-risk mother might face in her pregnancy.

Clinically, we provide full prenatal care, maternal and fetal disease consultation, prenatal diagnosis, and genetic counseling. We currently support over a dozen clinical sites in Colorado and Wyoming. We are also proud to support the Children’s Hospital of Colorado's Colorado Fetal Care Center (CFCC) which specializes in fetal diagnosis and in utero intervention.

We are dedicated to the development of highly successful Maternal-Fetal Medicine fellows. We provide critical high-risk obstetrics education to the University of Colorado residents and medical students both on the wards and in classroom settings. We have strong basic science and clinical research programs and work collaboratively with the Division of Reproductive Sciences and other divisions across the University of Colorado.

cu-obgyn-maternal-fetal-medicine-vision-statement

The Division of Maternal-Fetal Medicine is committed to improving the health of pregnant women and their babies through clinical, translational, and basic research. Research interests of the MFM division range from innovative mechanistic studies underlying uterine and placental function to state-of-the-art sonographic evaluation of fetal consequences of growth restriction to cutting-edge observational, quality improvement, and clinical trials encompassing the field of maternal-fetal medicine.

The division has strong collaborative research with other departments and entities including the Children’s Hospital Colorado Fetal Care Center, Perinatal Research Center, and the Departments of Psychiatry, Infectious Disease, Medicine (Endocrinology) and Pediatrics.

For more details, please click on the links below.

 


 

Early and late contribution of fasting and postprandial triglycerides on newborn subcutaneous and intrahepatic fat in obese pregnancies

This study plans to learn more about how triglyceride levels in pregnancy affect newborn fat mass. Obesity in pregnancy, in the absence of gestational diabetes, is now the most common cause of large-for-gestational-age infants and increased newborn fat mass. Previous data supports the idea that maternal triglycerides, not glucose, are the strongest predictor of both total newborn fat mass and liver fat. In this study, mothers will monitor triglyceride and glucose levels at specific points in pregnancy using point-of-care meters at home. Two weeks after birth, infants will have total fat measured by air-displacement plethysmography (PEAPOD) and liver fat measures by Magnetic Resonance Spectroscopy (MRS). The central hypothesis is that in obesity, fasting triglycerides and postprandial triglycerides will predict newborn fat mass in a free-living environment.
Learn More

Faculty: ​Linda A Barbour, MD, MSPH,
Funding Source: The American Diabetes Association
Funding Dates: 01/01/21-07Principal Investigator/31/23

Randomized controlled trial of intervention targeting elevated triglycerides with a point-of-care meter and omega-3 fatty acids to normalize triglycerides and fetal growth

This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are ~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.
Learn More

Faculty: ​Linda A Barbour, MD, MSPH, Sub-Investigator
Funding Source: Harold Hamm Diabetes Center and Presbyterian Health Foundation Team Science Grants
Funding Dates: 07/01/20-07/31/23

Effects of High Altitude on AMPK Activation and PPARY Regulation

Faculty: ​Anna Euser, MD, PhD, Principal Investigator

Preconception Counseling: Identifying Ways to Improve Services

Faculty: ​Teresa Harper, MD, Principal Investigator

Preconception Counseling: Prospective evaluation of subsequent pregnancy outcomes

Faculty: ​Teresa Harper, MD, Principal Investigator

Perelman Fetal Growth Restriction Study

The investigation will employ a longitudinal approach in which every fetus diagnosed to be SGA (Small for Gestational Age ) will be studied at frequent intervals with sophisticated imaging techniques to assess subtle physiologic changes in the brain, heart, and placenta over time. These findings will be correlated with neurological and cardiovascular function in the newborn and early childhood. This research initiative should yield diagnostic and therapeutic templates that will improve the quality of life of IUGR babies in addition to providing important information that will better inform current diagnostic practices. The overarching objective is to serially assess changes in the fetal circulation, heart, and brain with sophisticated ultrasound, MRI (Magnetic Resonance Imaging), and body composition techniques that will provide clues as to how growth restricted babies will tolerate life outside the uterus. Employing a longitudinal study will allow the investigators to correlate perinatal and postnatal outcomes more comprehensively than previous studies.
Learn More

Faculty: ​John Hobbins, MD, Principal Investigator
Funding Source: The Perelman Family Foundation
Funding Dates: 04/01/15-10/31/22

Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms

Exposure to maternal depressive symptoms is one of the most well established risk factors for the development of later child psychopathology. Accumulating evidence from naturalistic observational studies documents that fetal exposure to maternal depressive symptoms is associated with risk for later child mental health problems. Maternal depression is one of the most common prenatal complications with approximately 40% of women experiencing elevated levels of depressive symptoms. The majority of past research has been correlational, so potential causal conclusions have been limited. This project will break new ground by testing the hypothesis that manipulating maternal depressive symptoms will benefit infant outcomes. In this project, maternal depressive symptoms will be reduced using brief interpersonal therapy (IPT), a well-established and efficacious treatment, and testing whether this reduction leads to an improvement in the development of infant mechanisms associated with risk for later psychopathology.
Learn More

Faculty: ​M. Camille Hoffman, MD, MSc, Co-Investigator
Funding Source: National Institute of Mental Health, R01 MH 109662
Funding Dates: 04/07/17-03/31/22

Double-blind Trial of Phosphatidylcholine Supplementation during Pregnancy: Impact on Attention and Social Withdrawal at 4 years of Age

The goal is to determine if providing a nutritional supplement, phosphatidylcholine, to pregnant women improves early brain development with improved brain-related development during the first four years of life. Participating pregnant women will receive either phosphatidylcholine or a placebo from approximately 16 weeks gestation through birth. The primary outcome is the child's behavior at four years of age as reported by the primary caregiver. Secondary outcomes include motor development, socio-emotional development, language development, and cognitive development. Potential contributors beyond the supplement, including maternal stress and placental function will also be assessed.
Learn More

Faculty: ​M. Camille Hoffman, MD, MSc, Principal Investigator
Funding Source: The Institute for Children's Mental Disorders
Funding Dates: 06/12/17-01/31/27

Unplanned Cesarean and associated morbidity in low-risk patients under midwifery or obstetrician care: A retrospective cohort study

Faculty: ​K. Joseph Hurt, MD, PhD, Principal Investigator
Learn more about the Preterm Labor Research Laboratory (aka Hurt Lab)

Identification and management of obstetric lacerations

Faculty: ​K. Joseph Hurt, MD, PhD, Principal Investigator
Learn more about the Preterm Labor Research Laboratory (aka Hurt Lab)

Oxidative stress, uterine blood flow, and intrauterine growth restrictions

Faculty: ​K. Joseph Hurt, MD, PhD, Principal Investigator
Learn more about the Preterm Labor Research Laboratory (aka Hurt Lab)
Funding Source: the Society for Maternal-Fetal Medicine and the American Association of Obstetricians and Gynecologists Foundation

Maternal fat signals regulating uterine contractility and parturition

Faculty: ​K. Joseph Hurt, MD, PhD, Principal Investigator
Learn more about the Preterm Labor Research Laboratory (aka Hurt Lab)
Funding Source: Ferring Innovation Grant

Comparison of non-invasive genetic screening methods among low-risk pregnant women

Faculty: ​Shane Reeves, MD, Principal Investigator

Complication rates of women diagnosed with COVID-19 in pregnancy

Faculty: ​Shane Reeves, MD, Principal Investigator

Comparing subcutaneous fat mass ratios in normally grown vs growth-restricted fetuses

Faculty: ​Shane Reeves, MD, Principal Investigator

Rate of short cervix in women with a history of prior preterm delivery between 20 and 34 weeks versus prior preterm delivery between 34 and 37 weeks

Faculty: ​Shane Reeves, MD, Principal Investigator

Concentrating in a Loud Crowd: Distractions in the Obstetrical Ultrasound Exam

Faculty: ​Heather Straub, MD, Principal Investigator

Marijuana use during pregnancy and fetal growth

Faculty: ​Heather Straub, MD, Principal Investigator

Evaluating clinical and healthcare outcomes from prenatal cannabis exposure surrounding recreational marijuana legalization in WA and CO (ECHO – WA & CO)

Faculty: ​Heather Straub, MD, Principal Investigator

Chronic hypertension and pregnancy (CHAP)

The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
Learn More

Faculty: ​Emily Su, MD, MSCI, Co-Investigator
Learn more about the Su Lab
Funding Source: the National Institutes of Health/National Heart Lung Blood Institute
Funding Dates: 06/01/15-06/31/22

Mediators of impaired fetoplacental angiogenesis in severe fetal growth restriction

Fetal growth and health are dependent upon proper fetoplacental blood flow - specifically, there should be forward blood flow from the fetus to the placenta through the umbilical artery and its placental branches. Growth-restricted fetuses with abnormal placental blood flow have inappropriately formed blood vessels and are at increased risks for suffering untoward events both during the perinatal period and long-term. This research project proposes to better understand regulatory features governing placental vessel development in hopes of targeting methods of improving fetoplacental blood flow and fetal/neonatal health.
Learn More

Faculty: ​Emily Su, MD, MSCI, Principal Investigator
Learn more about the Su Lab
Funding Source: the National Institutes of Health
Funding Dates: 08/01/14-04/30/20

Obstetrical and neonatal complications associated with use of integrase inhibitors in HIV-positive pregnant women

Faculty: ​Joyce Sung, MD, Principal Investigator

Co-investigator in multi-center clinical trials examining use of HIV antiretroviral medications in pregnancy

Faculty: ​Joyce Sung, MD, Co-Investigator

 


 

Sonographic measurements of fetal mass in the third trimester

Fellow: ​Emily Willner, MD

Covid-19 and Pregnancy at University of Colorado Hospital

Fellow: ​Odessa Hamidi, MD

 


 

Industry Research

The division regularly partners with industry sponsors for pregnancy-related studies. Please contact Jocelyn Phipers, RN, CCRP for information on potential collaborations with the Division of Maternal Fetal Medicine at the University of Colorado.

CU Maternal-Fetal Medicine, Boulder
Boulder Community Hospital Foothills Campus
4747 Arapahoe Avenue
Boulder, CO 80303
Phone: (303) 415-7544
Fax: (720) 854-7520

CU Maternal-Fetal Medicine, Greeley
1715 61st Avenue
Greeley, CO 80634
Phone: (970) 336-1500
Fax: (970) 336-1505

CU Maternal-Fetal Medicine
Cheyenne Women's Clinic
3952 Parkview Drive
Cheyenne, WY 82001
Phone: (307) 637-7700
Fax: (307) 637-5672

CU John C. Hobbins Perinatal Center
Previously Platte River Perinatal Center
1875 Lawrence Street, Suite 350
Denver, CO 80202
Phone: (303) 315-6100, opt 1
Fax: (303) 468-3481

CU Parker Perinatal Center
9397 Crown Crest Boulevard
Alpine Suite 310
Parker, CO 80138
Phone: (303) 315-6100, opt 2
Fax: (303) 840-4713

CU Specialty Care at Highlands Ranch - Maternal-Fetal Medicine
1500 Park Central Drive
Suites 302, 402
Highlands Ranch, CO 80129
Phone: (303) 315-6100

Lone Tree High Risk OB Clinic
9548 Park Meadows Drive
Lone Tree, CO 80124
Phone: (720) 848-2200

High Country Healthcare
360 Peak One Drive, Suite 260
Frisco, CO 80443
Phone: (970) 668-5771
Fax: (970) 262-2196

CU Maternal-Fetal Medicine, Anschutz
UCHealth
1635 Aurora Court, 3rd Floor
Aurora, CO 80045
Phone: (720) 848-1060
Fax: (720) 848-184

CU Littleton Perinatal Center
7720 S. Broadway, Suite 190
190 Littleton, CO 80122
Phone: (303) 315-6100, opt 3
Fax: (303) 468-3481

CFCC: Colorado Fetal Care Center
Children's Hospital Colorado, Anschutz Medical Campus
13123 E. 16th Avenue
Aurora, CO 80045
Phone: (855) 413-3825
Fax: (720) 777-7960

CHCO North: CU Perinatal Center
Children’s Hospital Colorado, North Campus
469 State Highway 7, Llama Floor (2nd Floor)
Broomfield, CO 80023
Phone: (720) 478-5545
Fax: (720) 777-7960

Yampa Telehealth
UCHealth Yampa Valley Medical Center – Women’s Care Clinic
1100 Central Park Drive, Suite 1000
Steamboat Springs, CO 80487
Phone: (970) 879-3738
Fax: (970) 870-6441

Northeast Colorado Family Medicine Associates, P.C.
1405 S. 8th Avenue, Suite 103
Sterling, CO 80751
Phone: (303) 315-6100
Fax: (303) 468-3481

Serving our Community

With 14 locations including telehealth sites throughout Colorado and Wyoming.

Experts in our Field

Including 21 Maternal-Fetal Medicine Providers, 2 Genetic Counselors and 1 Nurse Practitioner.

 

Contact Info

Andrea Cook, MHA
Division Administrative Director
12631 East 17th Avenue
Room 4109, B198-5
Aurora, CO 80045

Phone: (303) 724-5625
Fax: (303) 724-2054

 

Amrita Shetty, MHA
Practice Manager

Phone: (303) 724-7698
Mobile: (720) 610-7897
Fax: (303) 724-2054

 

Cindy Geckas, BS
Business Support Specialist III

Phone: (303) 724-2032
Fax: (303) 724-2054

 

 

Clinic Info

 

 

Contact Info

Andrea Cook, MHA
Division Administrative Director
12631 East 17th Avenue
Room 4109, B198-5
Aurora, CO 80045

Phone: (303) 724-5625
Fax: (303) 724-2054

 

Amrita Shetty, MHA
Practice Manager

Phone: (303) 724-7698
Mobile: (720) 610-7897
Fax: (303) 724-2054

 

Cindy Geckas, BS
Business Support Specialist III

Phone: (303) 724-2032
Fax: (303) 724-2054

 

 

Clinic Info